Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions

Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie); FAO, Rome (Italy). Animal Production and Health Div. eng; FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France); Garin-Bastuji, B. (ed.); Benkirane, A. (ed.); Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre

Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions

Summary (En)

Saved in:

Bibliographic Details
Main Authors:	Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie), FAO, Rome (Italy). Animal Production and Health Div. eng, FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France), Garin-Bastuji, B. (ed.), Benkirane, A. (ed.), Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre
Format:	Texto biblioteca
Language:
Published:	Maisons-Alfort (France) CNEVA 1995
Subjects:	BRUCELLA MELITENSIS, VACCINES, IMMUNOLOGY, SAFETY, BRUCELLOSIS, VACCIN, VACUNA, IMMUNOLOGIE, SECURITE, BRUCELLOSE, INMUNOLOGIA, SEGURIDAD, BRUCELOSIS,
Tags:	Add Tag No Tags, Be the first to tag this record!

id	unfao:801868
record_format	koha
spelling	unfao:8018682014-12-22T12:10:18ZEfficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie) FAO, Rome (Italy). Animal Production and Health Div. eng FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France) Garin-Bastuji, B. (ed.) Benkirane, A. (ed.) Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre textMaisons-Alfort (France) CNEVA1995 Summary (En)Summary (En)BRUCELLA MELITENSISVACCINESIMMUNOLOGYSAFETYBRUCELLOSISBRUCELLA MELITENSISVACCINBRUCELLA MELITENSISVACUNAIMMUNOLOGIESECURITEBRUCELLOSEINMUNOLOGIASEGURIDADBRUCELOSIS(Proceedings)366307-323
institution	FAO IT
collection	Koha
country	Italia
countrycode	IT
component	Bibliográfico
access	En linea
databasecode	cat-fao-it
tag	biblioteca
region	Europa del Sur
libraryname	David Lubin Memorial Library of FAO
language
topic	BRUCELLA MELITENSIS VACCINES IMMUNOLOGY SAFETY BRUCELLOSIS BRUCELLA MELITENSIS VACCIN BRUCELLA MELITENSIS VACUNA IMMUNOLOGIE SECURITE BRUCELLOSE INMUNOLOGIA SEGURIDAD BRUCELOSIS BRUCELLA MELITENSIS VACCINES IMMUNOLOGY SAFETY BRUCELLOSIS BRUCELLA MELITENSIS VACCIN BRUCELLA MELITENSIS VACUNA IMMUNOLOGIE SECURITE BRUCELLOSE INMUNOLOGIA SEGURIDAD BRUCELOSIS
spellingShingle	BRUCELLA MELITENSIS VACCINES IMMUNOLOGY SAFETY BRUCELLOSIS BRUCELLA MELITENSIS VACCIN BRUCELLA MELITENSIS VACUNA IMMUNOLOGIE SECURITE BRUCELLOSE INMUNOLOGIA SEGURIDAD BRUCELOSIS BRUCELLA MELITENSIS VACCINES IMMUNOLOGY SAFETY BRUCELLOSIS BRUCELLA MELITENSIS VACCIN BRUCELLA MELITENSIS VACUNA IMMUNOLOGIE SECURITE BRUCELLOSE INMUNOLOGIA SEGURIDAD BRUCELOSIS Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie) FAO, Rome (Italy). Animal Production and Health Div. eng FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France) Garin-Bastuji, B. (ed.) Benkirane, A. (ed.) Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
description	Summary (En)
format	Texto
topic_facet	BRUCELLA MELITENSIS VACCINES IMMUNOLOGY SAFETY BRUCELLOSIS BRUCELLA MELITENSIS VACCIN BRUCELLA MELITENSIS VACUNA IMMUNOLOGIE SECURITE BRUCELLOSE INMUNOLOGIA SEGURIDAD BRUCELOSIS
author	Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie) FAO, Rome (Italy). Animal Production and Health Div. eng FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France) Garin-Bastuji, B. (ed.) Benkirane, A. (ed.) Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre
author_facet	Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie) FAO, Rome (Italy). Animal Production and Health Div. eng FAO/WHO/OIE Round Table on the Use of Rev.1 Vaccine in Small Ruminants and Cattle eng 21-22 Sep 1995 Maisons-Alfort (France) Garin-Bastuji, B. (ed.) Benkirane, A. (ed.) Centre National d'Etudes Veterinaires et Alimentaires, Maisons-Alfort (France) fre
author_sort	Verger, J.M. (Institut National de la Recherche Agronomique, Nouzilly (France). Lab. de Pathologie Infectieuse et d'Immunologie)
title	Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
title_short	Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
title_full	Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
title_fullStr	Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
title_full_unstemmed	Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions
title_sort	efficacy and advantages of the rev.1 conjunctival vaccine against b. melitensis infection, as evaluated in standard controlled conditions
publisher	Maisons-Alfort (France) CNEVA
publishDate	1995
work_keys_str_mv	AT vergerjminstitutnationaldelarechercheagronomiquenouzillyfrancelabdepathologieinfectieuseetdimmunologie efficacyandadvantagesoftherev1conjunctivalvaccineagainstbmelitensisinfectionasevaluatedinstandardcontrolledconditions AT faoromeitalyanimalproductionandhealthdiveng efficacyandadvantagesoftherev1conjunctivalvaccineagainstbmelitensisinfectionasevaluatedinstandardcontrolledconditions AT faowhooieroundtableontheuseofrev1vaccineinsmallruminantsandcattleeng2122sep1995maisonsalfortfrance efficacyandadvantagesoftherev1conjunctivalvaccineagainstbmelitensisinfectionasevaluatedinstandardcontrolledconditions AT garinbastujibed efficacyandadvantagesoftherev1conjunctivalvaccineagainstbmelitensisinfectionasevaluatedinstandardcontrolledconditions AT benkiraneaed efficacyandadvantagesoftherev1conjunctivalvaccineagainstbmelitensisinfectionasevaluatedinstandardcontrolledconditions AT centrenationaldetudesveterinairesetalimentairesmaisonsalfortfrancefre efficacyandadvantagesoftherev1conjunctivalvaccineagainstbmelitensisinfectionasevaluatedinstandardcontrolledconditions
_version_	1768409731254190080

Efficacy and advantages of the Rev.1 conjunctival vaccine against B. melitensis infection, as evaluated in standard controlled conditions

Similar Items

Resource Map